vs

Side-by-side financial comparison of Forward Industries, Inc. (FWDI) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($37.2M vs $21.4M, roughly 1.7× Forward Industries, Inc.). On growth, Forward Industries, Inc. posted the faster year-over-year revenue change (224.0% vs -57.1%). Over the past eight quarters, Forward Industries, Inc.'s revenue compounded faster (74.6% CAGR vs -46.5%).

Melrose Industries plc is a British aerospace manufacturing company based in Birmingham, England. It is the parent company of GKN Aerospace. The company's shares are listed on the London Stock Exchange as a constituent of the FTSE 100 Index.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

FWDI vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.7× larger
ORGO
$37.2M
$21.4M
FWDI
Growing faster (revenue YoY)
FWDI
FWDI
+281.1% gap
FWDI
224.0%
-57.1%
ORGO
Faster 2-yr revenue CAGR
FWDI
FWDI
Annualised
FWDI
74.6%
-46.5%
ORGO

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
FWDI
FWDI
ORGO
ORGO
Revenue
$21.4M
$37.2M
Net Profit
$-585.7M
Gross Margin
78.6%
30.8%
Operating Margin
-2722.8%
-185.1%
Net Margin
-2732.2%
Revenue YoY
224.0%
-57.1%
Net Profit YoY
-82611.5%
EPS (diluted)
$-5.91

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FWDI
FWDI
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$21.4M
$225.6M
Q3 25
$7.9M
$150.9M
Q2 25
$2.5M
$101.0M
Q1 25
$3.1M
$86.7M
Q4 24
$6.6M
$126.7M
Q3 24
$115.2M
Q2 24
$7.8M
$130.2M
Net Profit
FWDI
FWDI
ORGO
ORGO
Q1 26
Q4 25
$-585.7M
$43.7M
Q3 25
$-164.0M
$21.6M
Q2 25
$-850.0K
$-9.4M
Q1 25
$-1.5M
$-18.8M
Q4 24
$-708.1K
$7.7M
Q3 24
$12.3M
Q2 24
$-399.6K
$-17.0M
Gross Margin
FWDI
FWDI
ORGO
ORGO
Q1 26
30.8%
Q4 25
78.6%
Q3 25
61.1%
Q2 25
Q1 25
-5.7%
72.6%
Q4 24
17.1%
75.5%
Q3 24
76.7%
Q2 24
16.8%
77.6%
Operating Margin
FWDI
FWDI
ORGO
ORGO
Q1 26
-185.1%
Q4 25
-2722.8%
28.1%
Q3 25
-39.2%
13.7%
Q2 25
-102.6%
-12.5%
Q1 25
-58.3%
-30.9%
Q4 24
-13.6%
8.1%
Q3 24
5.4%
Q2 24
-5.9%
-10.7%
Net Margin
FWDI
FWDI
ORGO
ORGO
Q1 26
Q4 25
-2732.2%
19.4%
Q3 25
-2063.6%
14.3%
Q2 25
-34.1%
-9.3%
Q1 25
-46.5%
-21.7%
Q4 24
-10.7%
6.1%
Q3 24
10.7%
Q2 24
-5.1%
-13.1%
EPS (diluted)
FWDI
FWDI
ORGO
ORGO
Q1 26
Q4 25
$-5.91
$0.31
Q3 25
$-21.86
$0.11
Q2 25
$-0.77
$-0.10
Q1 25
$-1.32
$-0.17
Q4 24
$-0.64
$0.05
Q3 24
$0.09
Q2 24
$-0.36
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FWDI
FWDI
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$91.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$880.9M
Total Assets
$892.9M
$520.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FWDI
FWDI
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$93.7M
Q3 25
$63.7M
Q2 25
$73.1M
Q1 25
$110.0M
Q4 24
$135.6M
Q3 24
$94.3M
Q2 24
$89.9M
Total Debt
FWDI
FWDI
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
FWDI
FWDI
ORGO
ORGO
Q1 26
Q4 25
$880.9M
$300.1M
Q3 25
$1.5B
$255.1M
Q2 25
$3.4M
$233.2M
Q1 25
$3.6M
$242.9M
Q4 24
$2.3M
$262.9M
Q3 24
$278.5M
Q2 24
$1.4M
$263.5M
Total Assets
FWDI
FWDI
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$892.9M
$598.7M
Q3 25
$1.5B
$509.8M
Q2 25
$8.3M
$461.1M
Q1 25
$12.3M
$467.4M
Q4 24
$497.9M
Q3 24
$446.3M
Q2 24
$15.2M
$443.2M
Debt / Equity
FWDI
FWDI
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FWDI
FWDI
ORGO
ORGO
Operating Cash FlowLast quarter
$-7.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FWDI
FWDI
ORGO
ORGO
Q1 26
Q4 25
$-7.9M
$39.4M
Q3 25
$-4.5M
$3.1M
Q2 25
$-1.2M
$-32.9M
Q1 25
$-537.6K
$-19.9M
Q4 24
$-434.3K
$10.9M
Q3 24
$8.7M
Q2 24
$436.0K
$4.7M
Free Cash Flow
FWDI
FWDI
ORGO
ORGO
Q1 26
Q4 25
$34.8M
Q3 25
$-4.5M
$844.0K
Q2 25
$-1.2M
$-36.5M
Q1 25
$-539.0K
$-23.6M
Q4 24
$-439.7K
$7.6M
Q3 24
$6.1M
Q2 24
$426.8K
$2.9M
FCF Margin
FWDI
FWDI
ORGO
ORGO
Q1 26
Q4 25
15.4%
Q3 25
-57.0%
0.6%
Q2 25
-50.0%
-36.1%
Q1 25
-17.3%
-27.2%
Q4 24
-6.6%
6.0%
Q3 24
5.3%
Q2 24
5.5%
2.2%
Capex Intensity
FWDI
FWDI
ORGO
ORGO
Q1 26
Q4 25
0.0%
2.1%
Q3 25
0.3%
1.5%
Q2 25
0.8%
3.6%
Q1 25
0.0%
4.2%
Q4 24
0.1%
2.7%
Q3 24
2.2%
Q2 24
0.1%
1.4%
Cash Conversion
FWDI
FWDI
ORGO
ORGO
Q1 26
Q4 25
0.90×
Q3 25
0.14×
Q2 25
Q1 25
Q4 24
1.43×
Q3 24
0.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FWDI
FWDI

CODM$17.4M81%
Design Segment$4.1M19%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons